Literature DB >> 18348205

A functional polymorphism, rs6280, in DRD3 is significantly associated with nicotine dependence in European-American smokers.

Weihua Huang1, Thomas J Payne, Jennie Z Ma, Ming D Li.   

Abstract

Nicotine enhances reward functions in the mesocorticolimbic dopamine system in general and the nucleus accumbens in particular. The genes encoding dopamine receptors are thus plausible candidates for involvement in nicotine dependence (ND). We investigated 13 single nucleotide polymorphisms (SNPs) spanning a region of the dopamine D(3) receptor gene (DRD3) to determine whether DRD3 is associated with ND. We studied a set of 2,037 subjects in 602 nuclear families representing two distinct American populations using three ND measures, namely, smoking quantity (SQ), the Heaviness of Smoking Index (HSI), and the Fagerström Test for ND (FTND). In the family based association study, we found that SNP rs6280 showed a strong association with ND in European-Americans (EAs) and the pooled sample, whereas SNPs rs1486012 and rs963468 had weak associations with ND in African-Americans (AAs) and the pooled sample. Further haplotype analysis with all contiguous 3-SNP groups revealed relatively weak evidence for association of DRD3 with ND in the EA and pooled samples. The results indicate that DRD3 is significantly associated with ND in EAs, and that rs6280, a functional polymorphism causing an amino acid change of serine to glycine (Ser9Gly) in the N-terminal extracellular domain of the D(3) receptor, likely is causative of the association between DRD3 and ND.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18348205     DOI: 10.1002/ajmg.b.30731

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  26 in total

1.  The dopamine D3 receptor gene and posttraumatic stress disorder.

Authors:  Erika J Wolf; Karen S Mitchell; Mark W Logue; Clinton T Baldwin; Annemarie F Reardon; Alison Aiello; Sandro Galea; Karestan C Koenen; Monica Uddin; Derek Wildman; Mark W Miller
Journal:  J Trauma Stress       Date:  2014-08

Review 2.  Neuroimaging, genetics and the treatment of nicotine addiction.

Authors:  Riju Ray; James Loughead; Ze Wang; John Detre; Edward Yang; Ruben Gur; Caryn Lerman
Journal:  Behav Brain Res       Date:  2008-06-05       Impact factor: 3.332

Review 3.  Pharmacogenetics of smoking cessation in general practice: results from the patch II and patch in practice trials.

Authors:  Sean P David; Elaine C Johnstone; Michael Churchman; Paul Aveyard; Michael F G Murphy; Marcus R Munafò
Journal:  Nicotine Tob Res       Date:  2011-01-25       Impact factor: 4.244

4.  Addiction-related genes in gambling disorders: new insights from parallel human and pre-clinical models.

Authors:  D S S Lobo; L Aleksandrova; J Knight; D M Casey; N el-Guebaly; J N Nobrega; J L Kennedy
Journal:  Mol Psychiatry       Date:  2014-09-30       Impact factor: 15.992

Review 5.  Current perspectives on selective dopamine D(3) receptor antagonists as pharmacotherapeutics for addictions and related disorders.

Authors:  Christian A Heidbreder; Amy H Newman
Journal:  Ann N Y Acad Sci       Date:  2010-02       Impact factor: 5.691

6.  The Role of Genetics in Nicotine Dependence: Mapping the Pathways from Genome to Syndrome.

Authors:  James Mackillop; Ezemenari Obasi; Michael T Amlung; John E McGeary; Valerie S Knopik
Journal:  Curr Cardiovasc Risk Rep       Date:  2010-11

7.  NKAIN1-SERINC2 is a functional, replicable and genome-wide significant risk gene region specific for alcohol dependence in subjects of European descent.

Authors:  Lingjun Zuo; Kesheng Wang; Xiang-Yang Zhang; John H Krystal; Chiang-Shan R Li; Fengyu Zhang; Heping Zhang; Xingguang Luo
Journal:  Drug Alcohol Depend       Date:  2013-02-28       Impact factor: 4.492

8.  Chronic cigarette smoking: implications for neurocognition and brain neurobiology.

Authors:  Timothy C Durazzo; Dieter J Meyerhoff; Sara Jo Nixon
Journal:  Int J Environ Res Public Health       Date:  2010-10-21       Impact factor: 3.390

9.  Common and unique biological pathways associated with smoking initiation/progression, nicotine dependence, and smoking cessation.

Authors:  Ju Wang; Ming D Li
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

10.  Further evidence for an association between the gamma-aminobutyric acid receptor A, subunit 4 genes on chromosome 4 and Fagerström Test for Nicotine Dependence.

Authors:  Arpana Agrawal; Michele L Pergadia; Sumitra Balasubramanian; Scott F Saccone; Anthony L Hinrichs; Nancy L Saccone; Naomi Breslau; Eric O Johnson; Dorothy Hatsukami; Nicholas G Martin; Grant W Montgomery; Alison M Goate; John P Rice; Laura J Bierut; Pamela A F Madden
Journal:  Addiction       Date:  2009-03       Impact factor: 6.526

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.